399 related articles for article (PubMed ID: 32760200)
1. Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.
Kumari A; Pal Pathak D; Asthana S
Int J Biol Sci; 2020; 16(13):2308-2322. PubMed ID: 32760200
[TBL] [Abstract][Full Text] [Related]
2. Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities.
Radun R; Trauner M
Semin Liver Dis; 2021 Nov; 41(4):461-475. PubMed ID: 34289507
[TBL] [Abstract][Full Text] [Related]
3. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.
Doege H; Baillie RA; Ortegon AM; Tsang B; Wu Q; Punreddy S; Hirsch D; Watson N; Gimeno RE; Stahl A
Gastroenterology; 2006 Apr; 130(4):1245-58. PubMed ID: 16618416
[TBL] [Abstract][Full Text] [Related]
4. Nuclear bile acid signaling through the farnesoid X receptor.
Mazuy C; Helleboid A; Staels B; Lefebvre P
Cell Mol Life Sci; 2015 May; 72(9):1631-50. PubMed ID: 25511198
[TBL] [Abstract][Full Text] [Related]
5. ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5).
Ason B; Castro-Perez J; Tep S; Stefanni A; Tadin-Strapps M; Roddy T; Hankemeier T; Hubbard B; Sachs AB; Michael Flanagan W; Kuklin NA; Mitnaul LJ
Lipids; 2011 Nov; 46(11):991-1003. PubMed ID: 21826528
[TBL] [Abstract][Full Text] [Related]
6. The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis.
Xiang D; Yang J; Liu L; Yu H; Gong X; Liu D
Biomed Pharmacother; 2023 Dec; 168():115606. PubMed ID: 37812893
[TBL] [Abstract][Full Text] [Related]
7. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
Wang S; Sheng F; Zou L; Xiao J; Li P
J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
[TBL] [Abstract][Full Text] [Related]
8. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
Molecules; 2020 May; 25(10):. PubMed ID: 32443832
[TBL] [Abstract][Full Text] [Related]
10. A Current Understanding of FXR in NAFLD: The multifaceted regulatory role of FXR and novel lead discovery for drug development.
Tang Y; Fan Y; Wang Y; Wang D; Huang Q; Chen T; Cao X; Wen C; Shen X; Li J; You Y
Biomed Pharmacother; 2024 Jun; 175():116658. PubMed ID: 38701562
[TBL] [Abstract][Full Text] [Related]
11. Discovery of farnesoid X receptor and its role in bile acid metabolism.
Chiang JYL; Ferrell JM
Mol Cell Endocrinol; 2022 May; 548():111618. PubMed ID: 35283218
[TBL] [Abstract][Full Text] [Related]
12. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity.
Hubbard B; Doege H; Punreddy S; Wu H; Huang X; Kaushik VK; Mozell RL; Byrnes JJ; Stricker-Krongrad A; Chou CJ; Tartaglia LA; Lodish HF; Stahl A; Gimeno RE
Gastroenterology; 2006 Apr; 130(4):1259-69. PubMed ID: 16618417
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
[TBL] [Abstract][Full Text] [Related]
14. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
15. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
Mueller M; Thorell A; Claudel T; Jha P; Koefeler H; Lackner C; Hoesel B; Fauler G; Stojakovic T; Einarsson C; Marschall HU; Trauner M
J Hepatol; 2015 Jun; 62(6):1398-404. PubMed ID: 25617503
[TBL] [Abstract][Full Text] [Related]
17. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
18. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
[TBL] [Abstract][Full Text] [Related]
19. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
